ENTA – enanta pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium [Yahoo! Finance]
Enanta Pharmaceuticals to Present Data for its Respiratory Syncytial Virus Program at the 13th International RSV Symposium
Enanta Pharmaceuticals, Inc. (NASDAQ: ENTA) was upgraded by analysts at StockNews.com from a "sell" rating to a "hold" rating.
President of Enanta Pharmaceuticals Picks Up 5.9% More Stock [Yahoo! Finance]
With Enanta Pharmaceuticals Up 46%, Insider Buyers Count Their Returns [Yahoo! Finance]
Form SCHEDULE 13D/A ENANTA PHARMACEUTICALS Filed by: Luly Jay R.
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Luu Brendan
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Kieffer Tara Lynn
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Rottinghaus Scott T.
Form 4 ENANTA PHARMACEUTICALS For: Feb 12 Filed by: Or Yat Sun
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.